Who is sponsoring NCT05075525?

NCT05075525 is sponsored by Istanbul Medipol University Hospital.

What drugs are being tested in NCT05075525?

Interventions in NCT05075525: High Intensity Laser Therapy Group, Ultrasound and Transcutaneous Electrical Nerve Stimulation Group, Ultrasound and Interferential Current Stimulation Group.

What condition does NCT05075525 study?

NCT05075525 studies Physical Therapy, Orthopedic Disorder.

Is NCT05075525 still recruiting?

NCT05075525 is currently status unknown. Last updated 12 October 2021.

Last reviewed 2021-10-12 · How we verify

NCT05075525: Laser

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EFFECT OF HIGH INTENSITY LASER IN PATELLOFEMORAL PAIN SYNDROME

Status unknown NA Last updated 12 October 2021

What this trial tests

NA trial testing High Intensity Laser Therapy Group in Physical Therapy in 45 participants. Status unknown.

Timeline

10 September 2021

Primary endpoint
10 March 2022

10 June 2022

Quick facts

Lead sponsor	Istanbul Medipol University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	45
Start date	10 September 2021
Primary completion	10 March 2022
Estimated completion	10 June 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

High Intensity Laser Therapy Group
Ultrasound and Transcutaneous Electrical Nerve Stimulation Group
Ultrasound and Interferential Current Stimulation Group

Conditions studied

Physical Therapy — all drugs for Physical Therapy →
Orthopedic Disorder — all drugs for Orthopedic Disorder →

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 25 to 45, any sex, with Physical Therapy or Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effectiveness of high-intensity laser therapy on pain and lower extremity function in the treatment of patellofemoral pain syndrome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of high-intensity laser therapy on pain and lower extremity function in patellofemoral pain syndrome: a single-blind randomized controlled trial.
Ozlu O, Atilgan E. · · 2024 · cited 7× · PMID 38630331 · DOI 10.1007/s10103-024-04017-y

Verify or expand the search:

Other recruiting trials for Physical Therapy

Currently open trials in the same condition.

NCT07451210 — Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitatio · NA · recruiting
NCT07251452 — Effectiveness of a Dual Program for Improving Sleep in Older Adults. · Phase 1, PHASE2 · active not recruiting
NCT06976164 — Reflexo Therapy for Gestational Diabetes Mellitus · NA · recruiting
NCT06755697 — Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Manage · NA · recruiting
NCT06590805 — Electroacupoint for Diminutive Milk Production · NA · recruiting

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05075525 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
Last refreshed: 12 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05075525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing